CN Stock MarketDetailed Quotes

Shaanxi Meibang Pharmaceutical Group (605033)

Watchlist
  • 23.06
  • 0.000.00%
Not Open May 15 09:30 CST
3.12BMarket Cap57.36P/E (TTM)

Shaanxi Meibang Pharmaceutical Group (605033) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
16.21%336.34M
2.98%911.95M
-2.23%608.89M
-4.76%485.33M
-7.27%289.41M
26.68%885.53M
12.49%622.78M
7.03%509.61M
-9.46%312.09M
-22.85%699.03M
Operating revenue
16.21%336.34M
2.98%911.95M
-2.23%608.89M
-4.76%485.33M
-7.27%289.41M
26.68%885.53M
12.49%622.78M
7.03%509.61M
-9.46%312.09M
-22.85%699.03M
Other operating revenue
----
-31.02%3.11M
----
-24.19%2.66M
----
-9.83%4.52M
----
-25.72%3.5M
----
689.11%5.01M
Total operating cost
11.67%283.97M
0.15%853.47M
-0.03%578.84M
-2.45%445.05M
-3.30%254.28M
33.23%852.21M
23.37%579.02M
19.42%456.22M
1.21%262.95M
-15.15%639.65M
Operating cost
10.61%212.57M
-5.23%599.62M
-5.97%405.52M
-8.36%325.32M
-9.73%192.19M
37.57%632.74M
21.63%431.27M
19.86%355M
1.65%212.89M
-11.36%459.93M
Operating tax surcharges
35.91%1.71M
11.14%5.98M
7.25%4.24M
3.16%2.79M
8.22%1.26M
57.58%5.38M
71.40%3.95M
68.83%2.7M
31.76%1.16M
-0.99%3.41M
Operating expense
26.39%40.33M
17.53%119.85M
21.96%80.47M
24.25%58.35M
33.66%31.91M
19.38%101.98M
14.98%65.97M
16.13%46.96M
8.74%23.88M
-30.35%85.42M
Administration expense
2.75%8.82M
11.11%43.57M
-1.01%27.23M
-0.20%17.36M
2.41%8.59M
15.85%39.22M
20.71%27.51M
11.59%17.39M
-0.77%8.39M
10.87%33.85M
Financial expense
241.14%164.3K
66.64%-477.91K
41.94%-659.52K
56.22%-379.08K
70.71%-116.41K
3.90%-1.43M
-5.61%-1.14M
-0.07%-865.88K
53.66%-397.44K
10.06%-1.49M
-Interest expense (Financial expense)
--247.12K
4,081.23%396.35K
202.47%28.67K
--0
----
-97.47%9.48K
-97.40%9.48K
-97.33%9.48K
--8.33K
-61.67%375.41K
-Interest Income (Financial expense)
24.58%-137.61K
30.36%-1.1M
30.26%-845.37K
49.22%-462.9K
56.70%-182.46K
21.15%-1.57M
20.01%-1.21M
28.11%-911.65K
52.58%-421.42K
27.39%-2M
Research and development
-0.41%20.37M
14.27%84.93M
20.61%62.05M
18.79%41.61M
20.10%20.45M
26.99%74.33M
54.14%51.45M
20.43%35.03M
-14.53%17.03M
-26.88%58.53M
Credit Impairment Loss
-42.64%-8.31M
-86.03%731.72K
31.79%-2.47M
23.14%-9.8M
8.26%-5.83M
112.11%5.24M
-5.78%-3.62M
-46.83%-12.76M
8.19%-6.35M
141.23%2.47M
Asset Impairment Loss
-172.36%-2.44M
-0.22%-21.44M
71.75%-1.57M
76.75%-1.14M
-20.07%-897.55K
-18.14%-21.4M
-820.08%-5.56M
-1,364.55%-4.9M
-247.05%-747.54K
-81.84%-18.11M
Other net revenue
-50.01%-7.73M
-151.60%-6.74M
-3.52%4.93M
10.74%-4.35M
-1,339.20%-5.15M
70.24%-2.68M
10,308.60%5.11M
31.36%-4.87M
107.38%415.68K
24.36%-9M
Fair value change income
--1.13M
85.61%867.55K
-15.53%1.04M
-33.41%714.47K
----
--467.41K
1,712.13%1.23M
1,483.47%1.07M
----
--0
Invest income
28.34%1.31M
-18.56%6.32M
-7.75%3.88M
-16.49%2.57M
-17.99%1.02M
69.31%7.76M
65.93%4.21M
65.96%3.08M
75.42%1.24M
11.47%4.58M
Other revenue
6.36%590.59K
29.11%6.79M
-54.24%4.05M
-61.69%3.31M
-91.15%555.3K
155.64%5.26M
--8.85M
--8.63M
--6.27M
--2.06M
Operating profit
48.92%44.64M
68.83%51.73M
-28.44%34.97M
-25.94%35.93M
-39.50%29.98M
-39.16%30.64M
-41.99%48.87M
-44.25%48.51M
-37.49%49.55M
-64.09%50.37M
Add:Non operating Income
-73.03%311.19K
-88.65%828.82K
-42.43%1.38M
-28.27%1.2M
4,877.44%1.15M
-40.88%7.3M
10.78%2.4M
-2.69%1.68M
-96.90%23.18K
-11.22%12.35M
Less:Non operating expense
-60.69%7.63K
116.65%188.88K
169.38%52.91K
467.02%42.88K
3,440.04%19.41K
-72.00%87.18K
-87.52%19.64K
-94.32%7.56K
-99.26%548.17
-82.90%311.34K
Total profit
44.46%44.95M
38.34%52.37M
-29.18%36.3M
-26.09%37.09M
-37.24%31.11M
-39.34%37.86M
-40.58%51.26M
-43.37%50.18M
-37.99%49.57M
-59.04%62.41M
Less:Income tax cost
703.79%9.33M
271.31%3.71M
-98.68%105.42K
-65.47%950.45K
-77.41%1.16M
-79.41%999.06K
-50.34%7.98M
-81.65%2.75M
-51.87%5.14M
-33.33%4.85M
Net profit
18.92%35.62M
32.03%48.66M
-16.36%36.2M
-23.81%36.14M
-32.60%29.95M
-35.96%36.86M
-38.34%43.28M
-35.57%47.43M
-35.85%44.44M
-60.33%57.56M
Net profit from continuing operation
18.92%35.62M
32.03%48.66M
-16.36%36.2M
-23.81%36.14M
-32.60%29.95M
-35.96%36.86M
-38.34%43.28M
-35.57%47.43M
-35.85%44.44M
-60.33%57.56M
Net profit of parent company owners
18.92%35.62M
32.03%48.66M
-16.36%36.2M
-23.81%36.14M
-32.60%29.95M
-35.96%36.86M
-38.34%43.28M
-35.57%47.43M
-35.85%44.44M
-60.33%57.56M
Earning per share
Basic earning per share
18.18%0.26
33.33%0.36
-15.63%0.27
-22.86%0.27
-33.33%0.22
-37.21%0.27
-38.46%0.32
-35.19%0.35
-35.29%0.33
-59.81%0.43
Diluted earning per share
18.18%0.26
33.33%0.36
-15.63%0.27
-22.86%0.27
-33.33%0.22
-37.21%0.27
-38.46%0.32
-35.19%0.35
-35.29%0.33
-59.81%0.43
Other composite income
Total composite income
18.92%35.62M
32.03%48.66M
-16.36%36.2M
-23.81%36.14M
-32.60%29.95M
-35.96%36.86M
-38.34%43.28M
-35.57%47.43M
-35.85%44.44M
-60.33%57.56M
Total composite income of parent company owners
18.92%35.62M
32.03%48.66M
-16.36%36.2M
-23.81%36.14M
-32.60%29.95M
-35.96%36.86M
-38.34%43.28M
-35.57%47.43M
-35.85%44.44M
-60.33%57.56M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Rongcheng Certified Public Accountants (Special General Partnership)
--
--
--
Rongcheng Certified Public Accountants (Special General Partnership)
--
--
--
Rongcheng Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 16.21%336.34M2.98%911.95M-2.23%608.89M-4.76%485.33M-7.27%289.41M26.68%885.53M12.49%622.78M7.03%509.61M-9.46%312.09M-22.85%699.03M
Operating revenue 16.21%336.34M2.98%911.95M-2.23%608.89M-4.76%485.33M-7.27%289.41M26.68%885.53M12.49%622.78M7.03%509.61M-9.46%312.09M-22.85%699.03M
Other operating revenue -----31.02%3.11M-----24.19%2.66M-----9.83%4.52M-----25.72%3.5M----689.11%5.01M
Total operating cost 11.67%283.97M0.15%853.47M-0.03%578.84M-2.45%445.05M-3.30%254.28M33.23%852.21M23.37%579.02M19.42%456.22M1.21%262.95M-15.15%639.65M
Operating cost 10.61%212.57M-5.23%599.62M-5.97%405.52M-8.36%325.32M-9.73%192.19M37.57%632.74M21.63%431.27M19.86%355M1.65%212.89M-11.36%459.93M
Operating tax surcharges 35.91%1.71M11.14%5.98M7.25%4.24M3.16%2.79M8.22%1.26M57.58%5.38M71.40%3.95M68.83%2.7M31.76%1.16M-0.99%3.41M
Operating expense 26.39%40.33M17.53%119.85M21.96%80.47M24.25%58.35M33.66%31.91M19.38%101.98M14.98%65.97M16.13%46.96M8.74%23.88M-30.35%85.42M
Administration expense 2.75%8.82M11.11%43.57M-1.01%27.23M-0.20%17.36M2.41%8.59M15.85%39.22M20.71%27.51M11.59%17.39M-0.77%8.39M10.87%33.85M
Financial expense 241.14%164.3K66.64%-477.91K41.94%-659.52K56.22%-379.08K70.71%-116.41K3.90%-1.43M-5.61%-1.14M-0.07%-865.88K53.66%-397.44K10.06%-1.49M
-Interest expense (Financial expense) --247.12K4,081.23%396.35K202.47%28.67K--0-----97.47%9.48K-97.40%9.48K-97.33%9.48K--8.33K-61.67%375.41K
-Interest Income (Financial expense) 24.58%-137.61K30.36%-1.1M30.26%-845.37K49.22%-462.9K56.70%-182.46K21.15%-1.57M20.01%-1.21M28.11%-911.65K52.58%-421.42K27.39%-2M
Research and development -0.41%20.37M14.27%84.93M20.61%62.05M18.79%41.61M20.10%20.45M26.99%74.33M54.14%51.45M20.43%35.03M-14.53%17.03M-26.88%58.53M
Credit Impairment Loss -42.64%-8.31M-86.03%731.72K31.79%-2.47M23.14%-9.8M8.26%-5.83M112.11%5.24M-5.78%-3.62M-46.83%-12.76M8.19%-6.35M141.23%2.47M
Asset Impairment Loss -172.36%-2.44M-0.22%-21.44M71.75%-1.57M76.75%-1.14M-20.07%-897.55K-18.14%-21.4M-820.08%-5.56M-1,364.55%-4.9M-247.05%-747.54K-81.84%-18.11M
Other net revenue -50.01%-7.73M-151.60%-6.74M-3.52%4.93M10.74%-4.35M-1,339.20%-5.15M70.24%-2.68M10,308.60%5.11M31.36%-4.87M107.38%415.68K24.36%-9M
Fair value change income --1.13M85.61%867.55K-15.53%1.04M-33.41%714.47K------467.41K1,712.13%1.23M1,483.47%1.07M------0
Invest income 28.34%1.31M-18.56%6.32M-7.75%3.88M-16.49%2.57M-17.99%1.02M69.31%7.76M65.93%4.21M65.96%3.08M75.42%1.24M11.47%4.58M
Other revenue 6.36%590.59K29.11%6.79M-54.24%4.05M-61.69%3.31M-91.15%555.3K155.64%5.26M--8.85M--8.63M--6.27M--2.06M
Operating profit 48.92%44.64M68.83%51.73M-28.44%34.97M-25.94%35.93M-39.50%29.98M-39.16%30.64M-41.99%48.87M-44.25%48.51M-37.49%49.55M-64.09%50.37M
Add:Non operating Income -73.03%311.19K-88.65%828.82K-42.43%1.38M-28.27%1.2M4,877.44%1.15M-40.88%7.3M10.78%2.4M-2.69%1.68M-96.90%23.18K-11.22%12.35M
Less:Non operating expense -60.69%7.63K116.65%188.88K169.38%52.91K467.02%42.88K3,440.04%19.41K-72.00%87.18K-87.52%19.64K-94.32%7.56K-99.26%548.17-82.90%311.34K
Total profit 44.46%44.95M38.34%52.37M-29.18%36.3M-26.09%37.09M-37.24%31.11M-39.34%37.86M-40.58%51.26M-43.37%50.18M-37.99%49.57M-59.04%62.41M
Less:Income tax cost 703.79%9.33M271.31%3.71M-98.68%105.42K-65.47%950.45K-77.41%1.16M-79.41%999.06K-50.34%7.98M-81.65%2.75M-51.87%5.14M-33.33%4.85M
Net profit 18.92%35.62M32.03%48.66M-16.36%36.2M-23.81%36.14M-32.60%29.95M-35.96%36.86M-38.34%43.28M-35.57%47.43M-35.85%44.44M-60.33%57.56M
Net profit from continuing operation 18.92%35.62M32.03%48.66M-16.36%36.2M-23.81%36.14M-32.60%29.95M-35.96%36.86M-38.34%43.28M-35.57%47.43M-35.85%44.44M-60.33%57.56M
Net profit of parent company owners 18.92%35.62M32.03%48.66M-16.36%36.2M-23.81%36.14M-32.60%29.95M-35.96%36.86M-38.34%43.28M-35.57%47.43M-35.85%44.44M-60.33%57.56M
Earning per share
Basic earning per share 18.18%0.2633.33%0.36-15.63%0.27-22.86%0.27-33.33%0.22-37.21%0.27-38.46%0.32-35.19%0.35-35.29%0.33-59.81%0.43
Diluted earning per share 18.18%0.2633.33%0.36-15.63%0.27-22.86%0.27-33.33%0.22-37.21%0.27-38.46%0.32-35.19%0.35-35.29%0.33-59.81%0.43
Other composite income
Total composite income 18.92%35.62M32.03%48.66M-16.36%36.2M-23.81%36.14M-32.60%29.95M-35.96%36.86M-38.34%43.28M-35.57%47.43M-35.85%44.44M-60.33%57.56M
Total composite income of parent company owners 18.92%35.62M32.03%48.66M-16.36%36.2M-23.81%36.14M-32.60%29.95M-35.96%36.86M-38.34%43.28M-35.57%47.43M-35.85%44.44M-60.33%57.56M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Rongcheng Certified Public Accountants (Special General Partnership)------Rongcheng Certified Public Accountants (Special General Partnership)------Rongcheng Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More